A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence Seizures

Abroad (travel likely)RecruitingPHASE2

Conditions

Epilepsy, Generalized · Epilepsy, Absence

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Clinical Trials, Inc. (CTI), Little Rock, Arkansas, United States
Contact: Study coordinator (Dusty Hollis-Holderfield) · dhholderfield@clinicaltrialsinc.com · 501-227-6179
Contact: Principal Investigator (Victor Biton, MD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome

Down Syndrome · Down Syndrome (DS) · Down Syndrome (Trisomy 21)

Abroad (travel likely)RecruitingPHASE3

Granada, Spain · Donostia / San Sebastian, Spain

Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy

Drug-Resistant Epilepsy · Epilepsy · Epilepsy (Treatment Refractory)

Abroad (travel likely)Recruiting

San Francisco, United States

A PET-MRI Study of Serotoninergic Brainstem Pathway in Patients With Dravet Syndrome

Epilepsy · Dravet Syndrome · Drug Resistant Epilepsy

Abroad (travel likely)Recruiting

Bron, France

Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents

Epilepsy · West Syndrome · Dravet Syndrome

Abroad (travel likely)Recruiting

Angers, France · Bordeaux, France